Roxadustat for CKD-related Anemia in Non-dialysis Patients

INTRODUCTION: Roxadustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor that stimulates erythropoiesis and improves iron metabolism. We assessed the efficacy and tolerability of roxadustat in patients with chronic kidney disease (CKD)-related anemia not on dialysis. METHODS: ANDES...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Kidney Int Rep
Autors principals: Coyne, Daniel W., Roger, Simon D., Shin, Sug Kyun, Kim, Sung Gyun, Cadena, Andres A., Moustafa, Moustafa A., Chan, Tak Mao, Besarab, Anatole, Chou, Willis, Bradley, Charles, Eyassu, Meraf, Leong, Robert, Lee, Tyson T., Saikali, Khalil G., Szczech, Lynda, Yu, Kin-Hung P.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2020
Matèries:
Clinical Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7938196/
https://ncbi.nlm.nih.gov/pubmed/33732977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2020.11.034
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars